Viewing Study NCT04762459

Home

Certify Doc

Genes

Clinical Trials

CompTox

DrugMatrix

Open Targets

Products

Support

Bugs

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-24 @ 2:47 PM

Ignite Modification Date: 2025-12-26 @ 4:14 PM

Study NCT ID: NCT04762459

Status: ENROLLING_BY_INVITATION

Last Update Posted: 2022-02-24

First Post: 2021-02-10

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Efficacy and Safety of Almonertinib Combined With or Without Chemotherapy as an Adjuvant Treatment for Stage II-IIIA Non-small Cell Lung Carcinoma Following Complete Tumour Resection

Sponsor: Chinese Academy of Medical Sciences

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module